IP Library › Assignment 042486/0322
Patent Assignment
Reel/Frame 042486/0322

Assignee and Correspondence Address Change

Recorded: 2017-05-17 Pages: 4
Assignor
Assignee
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
4000 CENTREGREEN WAY, SUITE 300, CARY, NORTH CAROLINA, 27513
Covered Property (1)
Method for Increasing the Bioavailability of Metaxalone
Patent: 6,407,128 →
Application: 09/998,206 →
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 7, 2003
From: ELAN PHARMACEUTICALS, INC.
To: JONES PHARMA INCORPORATED
Reel/Frame 014235/0344 →
Merger and Change of Name Mar 6, 2007
From: JONES PHARMA INCORPORATED
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC
Reel/Frame 018961/0829 →
Security Agreement Dec 30, 2008
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0870 →
Release of Security Interest May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0022 →
Security Agreement May 13, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 025703/0628 →
Release of Security Interest Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 025738/0132 →